The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung.
Kawahara
K
K
First Department of Surgery, Nagasaki University School of Medicine, Japan.
Tagawa
T
T
Takahashi
T
T
Akamine
S
S
Nakamura
A
A
Yamamoto
S
S
Muraoka
S
S
Tomita
M
M
D000818:Animals; D004285:Dogs; D007511:Ischemia; D007546:Isoquinolines / Q000494:pharmacology*; D007958:Leukocyte Count; D008168:Lung / Q000098:blood supply*; D008170:Lung Compliance; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D011652:Pulmonary Circulation; D011726:Pyridinium Compounds / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*; D044005:Tetrahydroisoquinolines; D014655:Vascular Resistance
D007546:Isoquinolines; D010972:Platelet Activating Factor; D011726:Pyridinium Compounds; D044005:Tetrahydroisoquinolines; C067430:TCV 309